LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Home・Aandelen Lijst・Dynavax Technologies Corp

Dynavax Technologies Corp

Gesloten

SectorGezondheidszorg

10.96 0.64

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.84

Max

11.17

Belangrijke statistieken
By Trading Economics
Inkomsten	8.2M 27M
Verkoop	-566K 95M
K/W Sectorgemiddelde	58.75 80.03
Winstmarge	28.381
Werknemers	405
EBITDA	7M 32M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+86.87% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	63M 1.3B
Vorige openingsprijs	10.32
Vorige sluitingsprijs	10.96

Nieuwssentiment

By Acuity

31%

69%

77 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

9.62 / 10.9 Steun & Weerstand

Dynavax Technologies Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 dec 2025, 23:48 UTC

Belangrijke Marktbewegers

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8 dec 2025, 23:44 UTC

Marktinformatie

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8 dec 2025, 23:42 UTC

Marktinformatie

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8 dec 2025, 23:13 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

8 dec 2025, 23:13 UTC

Marktinformatie

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8 dec 2025, 23:09 UTC

Acquisities, Fusies, Overnames

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8 dec 2025, 22:46 UTC

Marktinformatie

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8 dec 2025, 22:01 UTC

Marktinformatie

Miners Poised to Do Well in 2026 -- Market Talk

8 dec 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8 dec 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8 dec 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8 dec 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8 dec 2025, 21:51 UTC

Marktinformatie

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8 dec 2025, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

8 dec 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

8 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

8 dec 2025, 21:38 UTC

Acquisities, Fusies, Overnames

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8 dec 2025, 21:38 UTC

Acquisities, Fusies, Overnames

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8 dec 2025, 21:36 UTC

Marktinformatie

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8 dec 2025, 21:20 UTC

Acquisities, Fusies, Overnames

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8 dec 2025, 21:12 UTC

Acquisities, Fusies, Overnames

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dec 2025, 21:08 UTC

Marktinformatie

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8 dec 2025, 20:38 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8 dec 2025, 20:26 UTC

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dec 2025, 20:18 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8 dec 2025, 20:07 UTC

Marktinformatie

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8 dec 2025, 20:06 UTC

Marktinformatie

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8 dec 2025, 20:05 UTC

Marktinformatie

Global Equities Roundup: Market Talk

8 dec 2025, 20:05 UTC

Marktinformatie

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8 dec 2025, 20:01 UTC

Marktinformatie

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Peer Vergelijking

Prijswijziging

Dynavax Technologies Corp Prognose

Koersdoel

By TipRanks

86.87% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 20.5 USD 86.87%

Hoogste 25 USD

Laagste 16 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Dynavax Technologies Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Dynavax Technologies Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

9.62 / 10.9Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

77 / 374 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.